IDiyas

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9624215 B1

PDFFull Text
Date of Patent:
Apr. 18, 2017

Filed:

Oct. 30, 2013

Amine derivative or salt thereof

Applicants:

Toyama Chemical Co., Ltd., Shinjuku-ku, JP;

Fujifilm Corporation, Minato-ku, JP;

Inventors:

Tadashi Tanaka, Toyama, JP;

Yoshitake Konishi, Toyama, JP;

Daisuke Kubo, Toyama, JP;

Masataka Fujino, Toyama, JP;

Issei Doi, Toyama, JP;

Daisuke Nakagawa, Kaisei, JP;

Tatsuya Murakami, Kaisei, JP;

Takayuki Yamakawa, Kaisei, JP;

Assignees:

TOYAMA CHEMICAL CO., LTD., Shinjuku-ku, JP;

FUJIFILM CORPORATION, Minato-ku, JP;

Attorney:

Oblon, McClelland, Maier & Neustadt, L.L.P.

Primary Examiner:

Samantha Shterengarts

Assistant Examiner:

Matt Mauro

Int. Cl.
CPC ...
A61K 31/455 (2006.01); A61K 31/4709 (2006.01); A61K 31/497 (2006.01); A61K 31/501 (2006.01); C07D 235/26 (2006.01); C07D 403/04 (2006.01); C07D 413/12 (2006.01); C07D 417/04 (2006.01); C07D 241/44 (2006.01); C07D 263/58 (2006.01); C07D 209/08 (2006.01); C07D 277/68 (2006.01); C07D 471/04 (2006.01); C07D 403/12 (2006.01); C07D 401/14 (2006.01); C07D 405/14 (2006.01); A61K 31/4035 (2006.01); A61K 31/404 (2006.01); A61K 31/416 (2006.01); A61K 31/4184 (2006.01); A61K 31/423 (2006.01); A61K 31/427 (2006.01); A61K 31/428 (2006.01); A61K 31/437 (2006.01); A61K 31/4439 (2006.01); A61K 31/454 (2006.01); A61K 31/4725 (2006.01); A61K 31/498 (2006.01); A61K 31/506 (2006.01); A61K 31/517 (2006.01); A61K 31/5377 (2006.01); A61K 31/538 (2006.01); C07D 213/80 (2006.01); C07D 215/38 (2006.01); C07D 217/24 (2006.01); C07D 231/56 (2006.01); C07D 401/04 (2006.01); C07D 235/08 (2006.01); C07D 401/06 (2006.01); C07D 401/12 (2006.01); C07D 417/06 (2006.01); C07D 417/12 (2006.01); C07D 209/12 (2006.01); C07D 209/34 (2006.01); C07D 209/38 (2006.01); C07D 209/42 (2006.01); C07D 209/46 (2006.01); C07D 209/48 (2006.01); C07C 211/45 (2006.01); C07D 209/04 (2006.01); C07D 215/227 (2006.01); C07D 239/88 (2006.01); C07D 265/36 (2006.01); C07D 401/10 (2006.01); C07D 407/14 (2006.01); C07D 413/06 (2006.01); C07D 413/10 (2006.01); C07D 413/14 (2006.01);
U.S. Cl.
CPC ...
C07D 471/04 (2013.01); A61K 31/404 (2013.01); A61K 31/4035 (2013.01); A61K 31/416 (2013.01); A61K 31/4184 (2013.01); A61K 31/423 (2013.01); A61K 31/427 (2013.01); A61K 31/428 (2013.01); A61K 31/437 (2013.01); A61K 31/4439 (2013.01); A61K 31/454 (2013.01); A61K 31/455 (2013.01); A61K 31/4709 (2013.01); A61K 31/4725 (2013.01); A61K 31/497 (2013.01); A61K 31/498 (2013.01); A61K 31/501 (2013.01); A61K 31/506 (2013.01); A61K 31/517 (2013.01); A61K 31/538 (2013.01); A61K 31/5377 (2013.01); C07C 211/45 (2013.01); C07D 209/04 (2013.01); C07D 209/08 (2013.01); C07D 209/12 (2013.01); C07D 209/34 (2013.01); C07D 209/38 (2013.01); C07D 209/42 (2013.01); C07D 209/46 (2013.01); C07D 209/48 (2013.01); C07D 213/80 (2013.01); C07D 215/227 (2013.01); C07D 215/38 (2013.01); C07D 217/24 (2013.01); C07D 231/56 (2013.01); C07D 235/08 (2013.01); C07D 235/26 (2013.01); C07D 239/88 (2013.01); C07D 241/44 (2013.01); C07D 263/58 (2013.01); C07D 265/36 (2013.01); C07D 277/68 (2013.01); C07D 401/04 (2013.01); C07D 401/06 (2013.01); C07D 401/10 (2013.01); C07D 401/12 (2013.01); C07D 401/14 (2013.01); C07D 403/04 (2013.01); C07D 403/12 (2013.01); C07D 405/14 (2013.01); C07D 407/14 (2013.01); C07D 413/06 (2013.01); C07D 413/10 (2013.01); C07D 413/12 (2013.01); C07D 413/14 (2013.01); C07D 417/04 (2013.01); C07D 417/06 (2013.01); C07D 417/12 (2013.01); Y02P 20/55 (2015.11);
Abstract

A novel amine derivative expressed by general formula (1) (in the formula: G, G, and Gare the same or different and represent CH or a nitrogen atom; Rrepresents a chlorine atom, an optionally-substituted Ccycloalkyl group, or the like; Rrepresents —COOR(in the formula, Rrepresents a hydrogen atom or a carboxyl protective group), or the like; Rrepresents a hydrogen atom, or the like; and Rrepresents an optionally-substituted condensed bicyclic hydrocarbon group, an optionally-substituted bicyclic heterocyclic group, or the like), or a salt thereof is useful in procedures such as the treatment or prevention of conditions related to excessive keratinocyte proliferation.

Find Patent Forward Citations

Loading…